Evidence of Neutralizing Antibodies Indicating the Cure of Patients Infected with COVID-19 Within one Month of Infection
- Authors: Abdulateef Y.1, Ayad Z.2, Noaman H.3, Fadhel M.4, Taha M.5, Rafeeq F.6, Salih A.7
-
Affiliations:
- Medical Microbiology Department, Medical College/ University of Anbar, Rumadi, Iraq
- Medical Chemistry Department, College of Medicine / Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq
- Department of Medicine, College of Medicine / University of Anbar, Rumadi, Iraq
- Medical Biotechnology, Lagash Laboratory, Baghdad, Iraq
- Medical Biochemistry, Lagash Land Laboratory, Baghdad, Iraq
- Department of Biology, Biology Lagash Land Laboratory, Baghdad, Iraq
- Pathological Analysis, Lagash Laboratory, Baghdad, Iraq
- Issue: Vol 22, No 4 (2024)
- Section: Medicine
- URL: https://rjeid.com/2211-3525/article/view/642325
- DOI: https://doi.org/10.2174/0122113525284502240217161226
- ID: 642325
Cite item
Full Text
Abstract
Background:During COVID-19 pandemic a major conflict facing the clinician where to prove cure of the patients.
Aims:The idea of confirming curability is based on clinical evaluation of the symptoms, laboratory investigations, and specific IgM, IgG anti-SARS-CoV2 antibodies.
Patients and Methods:All patients had presented with clinical features of COVID-19 positive PCR attended private clinic doctors consultant in internal medicine and infectious diseases, they did investigations in Lagash land private medical laboratory in Baghdad investigated and screened for COVID-19 by S. ferritin, D-dimer, Complete blood picture and LDH. All were reevaluated in the first month of infection by clinical examination, retesting, and screening for COVID-19 IgM IgG later to prove cure or evidence of viral infection in PCR negative cases.
Results:All patients are of different ages with maximum years affected from adulthood till the age of one hundred years. Male were 170(54.3%) patients and females were 143 (45.7%) total 313 patients (100%). Most are moderate socioeconomic status, with a significant number having comorbidities.
Conclusion:SARS COVID-19 IgM, IgG levels can be used to confirm a cure of the infection
Keywords
About the authors
Yasir Abdulateef
Medical Microbiology Department, Medical College/ University of Anbar, Rumadi, Iraq
Email: info@benthamscience.net
Zainab Ayad
Medical Chemistry Department,College of Medicine / Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq
Email: info@benthamscience.net
Haitham Noaman
Department ofMedicine, College of Medicine / University of Anbar, Rumadi, Iraq
Author for correspondence.
Email: info@benthamscience.net
Marwa Fadhel
Medical Biotechnology, Lagash Laboratory, Baghdad,Iraq
Email: info@benthamscience.net
Mahammad Taha
Medical Biochemistry, Lagash Land Laboratory, Baghdad, Iraq
Email: info@benthamscience.net
Fatima Rafeeq
Department of Biology, Biology LagashLand Laboratory, Baghdad, Iraq
Email: info@benthamscience.net
Ahmed Salih
Pathological Analysis, Lagash Laboratory, Baghdad, Iraq
Email: info@benthamscience.net
Supplementary files
